Chai Discovery Headlines

GEN (Genetic Engineering & Biotechnology News)

Eli Lilly announced collaborations with several partners, including Chai Discovery, to expand its AI footprint in drug discovery.

Companies:Chai Discovery

Yahoo Finance

A new Pulse Report from BCC Research highlights how AI is transforming neuroprotective therapies. Chai Discovery is listed among companies that recently raised significant venture capital, with $70 million.

Companies:Chai Discovery

AI World Journal

Chai Discovery is highlighted as a notable example of AI-driven biotechnology, developing advanced AI models to predict and reprogram interactions between biochemical molecules. Their generative AI platform designs antibodies and therapeutic molecules, accelerating drug discovery. The company is backed by major investors including OpenAI and leading venture capital firms, treating biology as an information system and drug discovery as a computational engineering challenge.

Companies:Chai Discovery

GEN - Genetic Engineering and Biotechnology News

Chai Discovery, an AI-driven biologics company, is developing therapeutics against undruggable targets using its Chai-2 model for de novo antibody design. They recently announced a collaboration with Eli Lilly to deploy Chai's technology for designing novel biologics and developing an exclusive AI model tailored to Lilly's discovery workflows. This partnership aims to accelerate drug discovery by reducing reliance on labor-intensive experimental screens.

Companies:Chai Discovery

Chai Discovery

This article from Chai Discovery announces our $70M Series A fundraise. It provides details about this new development.

Companies:Chai Discovery

Bloomberg

OpenAI and Thrive Capital have invested in a six-month-old AI drug-discovery startup. This funding round supports the nascent company's efforts to leverage artificial intelligence in the development of new drugs. The article from Bloomberg reports on this significant backing for the young startup.

Companies:Chai Discovery